Clinical Trial Update: Gallium-68 PSMA-11 Positron Emission Tomography (PET) Imaging in Patients With Biochemical Recurrence [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Gallium-68 PSMA-11 PET imaging in patients with biochemical recurrence of prostate cancer; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Gallium-68 PSMA-11 PET imaging (Gallium-68 PSMA-11)

Snippet

Sponsor: Thomas Hope | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2021-10-21